BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1678133)

  • 1. Bidirectional potentiation between D1 and D2 dopamine agonists: effects of unilateral intra-accumbens injections on locomotor activity in mice.
    Messier C; Mrabet O; Durkin TP; Destrade C
    Life Sci; 1991; 49(9):PL43-8. PubMed ID: 1678133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists.
    Messier C; Mrabet O; Destrade C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):177-82. PubMed ID: 1347172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I; Bryer JB; Starkstein SE; Honig M; Moran TH; Robinson RG
    Brain Res; 1990 Nov; 533(2):286-91. PubMed ID: 1981170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats.
    Saigusa T; Koshikawa N; Kitamura M; Kobayashi M
    Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of quinpirole in the nucleus accumbens depending on the initial level of locomotor activity.
    Wu M; Brudzynski SM; Mogenson GJ
    Brain Res Bull; 1993; 32(4):395-8. PubMed ID: 8106125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon the behavioural satiety sequence.
    Phillips GD; Howes SR; Whitelaw RB; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1995 Jan; 117(1):82-90. PubMed ID: 7724706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity.
    Plaznik A; Stefanski R; Kostowski W
    Psychopharmacology (Berl); 1989; 99(4):558-62. PubMed ID: 2594923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats.
    Wahnschaffe U; Löscher W
    Brain Res; 1991 Jul; 553(2):181-7. PubMed ID: 1681980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissimilarities between cholinergic and dopaminergic turning elicited by nucleus accumbens stimulation in freely moving rats.
    Saigusa T; Koshikawa N; Kitamura M; Mizutani K; Kobayashi M; Cools AR
    Eur J Pharmacol; 1995 Feb; 274(1-3):213-20. PubMed ID: 7539377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin.
    Liang RZ; Wu M; Yim CC; Mogenson GJ
    Brain Res; 1991 Jul; 554(1-2):85-94. PubMed ID: 1681991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine.
    Essman WD; McGonigle P; Lucki I
    Psychopharmacology (Berl); 1993; 112(2-3):233-41. PubMed ID: 7871025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens.
    Yang CR; Mogenson GJ
    Brain Res; 1989 Jun; 489(2):237-46. PubMed ID: 2568154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists.
    Kaddis FG; Wallace LJ; Uretsky NJ
    Pharmacol Biochem Behav; 1993 Nov; 46(3):703-8. PubMed ID: 7506423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.